Leading CMO purchases multiple GMP scale twin-column units
Continuous chromatography technology now planned for production suites to give CMO a leading edge with new therapies at attractive cost point. Patented MCSGP will significantly increase yield of oligo and peptide production.
Previous Article
FDA purchases YMC technology Related Posts
August 14, 2025
Thank you for giving back, Theresa!
What an awesome use of Theresa's Employee Volunteer Time - helping veterans!
July 23, 2025
Visit us at NACRW!
YMC America looks forward to connecting with fellow scientists and industry leaders at the North American Chemical Residue Workshop (NACRW), July 27-30, 2025, booth #6 in the Francis Marion Hotel, Charleston, South Carolina.
July 16, 2025
Enrichment of Full AAV2 Using Multicolumn Countercurrent Solvent Gradient Purification (MCSGP)
Read our latest article on enhancing Adeno-associated virus (AAV) purity for gene therapy titled Enrichment of Full AAV2 Using Multicolumn Countercurrent Solvent Gradient Purification (MCSGP). AAVs are powerful delivery vehicles, but separating full (therapeutic) from empty capsids has been a
